• Privacy Policy
  • Contacts
+39 085 295166 info@nsmcongressi.it
Haemosafety Haemosafety
  • Who we are
  • Topics
    • Emerging infections
    • Prion diseases
    • Viral infections: Epidemiology and treatment
    • Security in replacement therapy, pharmacovigilance and haemovigilance
    • Therapeutic advances
    • Zika Virus
  • Link
  • Subscribe to the newsletter
  • en
  • it
Home

Archive for Category: sicurezza terapia

Nov 20 2017

Occult hepatitis B infection and transfusion-transmission risk

sicurezza terapia

Despite the availability of a vaccine and the continuous development of antiviral treatments, persistent...

Read More

Nov 07 2017

Is there a relationship between Alzheimer disease and blood transfusion?

sicurezza terapia

A recent study published in Molecular Psychiatry has shown for the first time that...

Read More

Oct 27 2017

Association between transfusion and mortality

sicurezza terapia

An important study on mortality in patients recipients of red blood cell transfusion has...

Read More

Sep 21 2017

Chagas disease in Europe: a review for the internist in the globalized world

sicurezza terapia

Chagas Diesease or American Tripanosomiasis is a disease transmitted by Tripanosoma Cruzii, endemic in...

Read More

Aug 03 2017

Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?

sicurezza terapia

Patients suffering from hematologic disorders (including leukemia, platelet disorders and coagulation factor deficiency) or...

Read More

Feb 09 2017

An inventory of concerns behind blood safety policies in five Western countries

sicurezza terapia

The availability of costly safety measures against transfusion-transmissible infections forces Western countries to confront...

Read More

Jan 31 2017

Safety Issues of Plasma-Derived Products for Treatment of Inherited Bleeding Disorders

sicurezza terapia

The infection by blood-borne pathogens of a large proportion of the treated hemophilia population...

Read More

Jan 31 2017

The current state of adverse event reporting in hemophilia

sicurezza terapia

ABSTRACT Introduction: Replacement of the missing clotting factor is the mainstay of hemophilia treatment....

Read More

Dec 21 2016

The risk of infection from Cytomegalovirus following transfusion

sicurezza terapia

Cytomegalovirus (CMV) is a ubiquitous virus belonging to the herpesvirus family. The most common...

Read More

Nov 22 2016

Protocol for a national blood transfusion data warehouse from donor to recipient

sicurezza terapia

Blood transfusion has health-related, economical and safety implications. In order to optimise the transfusion...

Read More
Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next
Copyright © 2021 Non Solo Meeting srl
CCIAA di Pescara n. 93080 - P.iva 01434640684 All Rights Reserved